phosphoserine has been researched along with neuropeptide y in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domin, H; Smiałowska, M; Wierońska, JM; Zieba, B | 1 |
Besik, V; Breit, A; Glas, E; Gudermann, T; Muehlich, S; Solinski, HJ; Yarwood, SJ | 1 |
2 other study(ies) available for phosphoserine and neuropeptide y
Article | Year |
---|---|
The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y.
Topics: Amino Acids, Dicarboxylic; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Autoradiography; Dose-Response Relationship, Drug; Hippocampus; In Situ Hybridization; Male; Microinjections; Neuropeptide Y; Phosphoserine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger | 2007 |
Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.
Topics: Animals; Bradykinin; Cell Line; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Genes, Reporter; Humans; Hypothalamus; Interferon-gamma; Ligands; Melanocyte-Stimulating Hormones; Mice; Neurons; Neuropeptide Y; Phosphorylation; Phosphoserine; Phosphotyrosine; Promoter Regions, Genetic; Receptors, Cytokine; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thyrotropin-Releasing Hormone; Transcriptional Activation | 2015 |